• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients.利用胰腺癌患者放疗前后的18F-FDG PET图像识别预后性肿瘤内异质性。
J Gastrointest Oncol. 2017 Feb;8(1):127-138. doi: 10.21037/jgo.2016.12.04.
2
Stratifying triple-negative breast cancer prognosis using 18F-FDG-PET/CT imaging.使用18F-FDG-PET/CT成像对三阴性乳腺癌预后进行分层。
Breast Cancer Res Treat. 2015 Oct;153(3):607-16. doi: 10.1007/s10549-015-3558-1. Epub 2015 Sep 7.
3
Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.基于[18F]-FDG 的 PET/CT 与 PET/MR 影像中影像组学特征的可互换性。
Med Phys. 2019 Apr;46(4):1677-1685. doi: 10.1002/mp.13422. Epub 2019 Feb 22.
4
Clinical utility of texture analysis of 18F-FDG PET/CT in patients with Stage I lung cancer treated with stereotactic body radiotherapy.18F-FDG PET/CT纹理分析在接受立体定向体部放疗的I期肺癌患者中的临床应用价值
J Radiat Res. 2017 Nov 1;58(6):862-869. doi: 10.1093/jrr/rrx050.
5
F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival.以免疫疗法治疗的晚期非小细胞肺癌中F-FDG Pet参数与放射组学特征分析作为治疗反应和生存的预测指标
Cancers (Basel). 2020 May 5;12(5):1163. doi: 10.3390/cancers12051163.
6
FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描放射组学预测局部进展期直肠癌的结局。
Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):365-375. doi: 10.1007/s00259-017-3855-5. Epub 2017 Oct 18.
7
Texture analysis of pretreatment [F]FDG PET/CT for the prognostic prediction of locally advanced salivary gland carcinoma treated with interstitial brachytherapy.用于预测接受间质近距离放疗的局部晚期涎腺癌预后的治疗前[F]FDG PET/CT纹理分析
EJNMMI Res. 2019 Sep 11;9(1):89. doi: 10.1186/s13550-019-0555-0.
8
Development and validation of a prognostic model incorporating [F]FDG PET/CT radiomics for patients with minor salivary gland carcinoma.纳入[F]FDG PET/CT 影像组学的小涎腺癌患者预后模型的开发与验证
EJNMMI Res. 2020 Jul 6;10(1):74. doi: 10.1186/s13550-020-00631-3.
9
Prognostic value of metabolic response measured by 18F-FDG-PET in oesophageal cancer patients treated with definitive chemoradiotherapy.18F-FDG-PET测量的代谢反应在接受根治性放化疗的食管癌患者中的预后价值
Nucl Med Commun. 2016 Dec;37(12):1282-1289. doi: 10.1097/MNM.0000000000000594.
10
[(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy.[(18)F]氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描代谢参数作为接受放化疗的宫颈癌患者有用的预后因素
Radiat Oncol. 2016 Mar 16;11:43. doi: 10.1186/s13014-016-0614-x.

引用本文的文献

1
Advancements in Radiomics-Based AI for Pancreatic Ductal Adenocarcinoma.基于放射组学的人工智能在胰腺导管腺癌中的进展。
Bioengineering (Basel). 2025 Aug 6;12(8):849. doi: 10.3390/bioengineering12080849.
2
Temporal Validation of an FDG-PET-Radiomic Model for Distant-Relapse-Free-Survival After Radio-Chemotherapy for Pancreatic Adenocarcinoma.胰腺癌放化疗后远处无复发生存的 FDG-PET 放射组学模型的时间验证
Cancers (Basel). 2025 Mar 20;17(6):1036. doi: 10.3390/cancers17061036.
3
Stereotactic body radiation therapy for the primary tumor and oligometastases versus the primary tumor alone in patients with metastatic pancreatic cancer.立体定向体部放疗联合转移灶寡转移治疗与单纯原发灶治疗转移性胰腺癌的疗效比较。
Radiat Oncol. 2024 Aug 19;19(1):111. doi: 10.1186/s13014-024-02493-8.
4
A nomogram based on CT texture features to predict the response of patients with advanced pancreatic cancer treated with chemotherapy.基于 CT 纹理特征的列线图预测接受化疗的晚期胰腺癌患者的反应。
BMC Gastroenterol. 2023 Aug 10;23(1):274. doi: 10.1186/s12876-023-02902-4.
5
Comprehensive multimodal management of borderline resectable pancreatic cancer: Current status and progress.可切除边缘胰腺癌的综合多模式管理:现状与进展
World J Gastrointest Surg. 2023 Feb 27;15(2):142-162. doi: 10.4240/wjgs.v15.i2.142.
6
Artificial Intelligence Applied to Pancreatic Imaging: A Narrative Review.人工智能应用于胰腺成像:一篇综述
Healthcare (Basel). 2022 Aug 11;10(8):1511. doi: 10.3390/healthcare10081511.
7
Application of artificial intelligence to pancreatic adenocarcinoma.人工智能在胰腺腺癌中的应用。
Front Oncol. 2022 Jul 22;12:960056. doi: 10.3389/fonc.2022.960056. eCollection 2022.
8
A systematic review of prognosis predictive role of radiomics in pancreatic cancer: heterogeneity markers or statistical tricks?基于影像组学的胰腺癌预后预测作用的系统评价:异质性标志物还是统计学技巧?
Eur Radiol. 2022 Dec;32(12):8443-8452. doi: 10.1007/s00330-022-08922-0. Epub 2022 Jul 29.
9
Prognostic Evaluation Based on Dual-Time F-FDG PET/CT Radiomics Features in Patients with Locally Advanced Pancreatic Cancer Treated by Stereotactic Body Radiation Therapy.基于双时相F-FDG PET/CT影像组学特征对接受立体定向体部放射治疗的局部晚期胰腺癌患者的预后评估
J Oncol. 2022 Jul 14;2022:6528865. doi: 10.1155/2022/6528865. eCollection 2022.
10
Potential advantages of FDG-PET radiomic feature map for target volume delineation in lung cancer radiotherapy.FDG-PET 放射组学特征图谱在肺癌放疗靶区勾画中的潜在优势。
J Appl Clin Med Phys. 2022 Sep;23(9):e13696. doi: 10.1002/acm2.13696. Epub 2022 Jun 14.

本文引用的文献

1
Lung texture in serial thoracic computed tomography scans: correlation of radiomics-based features with radiation therapy dose and radiation pneumonitis development.胸部计算机断层扫描序列中的肺纹理:基于影像组学特征与放射治疗剂量及放射性肺炎发生的相关性
Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):1048-56. doi: 10.1016/j.ijrobp.2014.11.030. Epub 2015 Feb 7.
2
Prognostic value and reproducibility of pretreatment CT texture features in stage III non-small cell lung cancer.Ⅲ期非小细胞肺癌治疗前CT纹理特征的预后价值及可重复性
Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):834-42. doi: 10.1016/j.ijrobp.2014.07.020. Epub 2014 Sep 11.
3
Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.基于(18)F-FDG PET/CT图像的纹理分析以鉴别骨与软组织的良恶性病变。
Ann Nucl Med. 2014 Nov;28(9):926-35. doi: 10.1007/s12149-014-0895-9. Epub 2014 Aug 9.
4
Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS).交界可切除胰腺癌:国际胰腺外科研究组(ISGPS)的共识声明。
Surgery. 2014 Jun;155(6):977-88. doi: 10.1016/j.surg.2014.02.001. Epub 2014 Feb 7.
5
Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: a meta-analysis.应用 F-18-氟代脱氧葡萄糖正电子发射断层扫描术诊断可疑胰腺癌的价值:一项荟萃分析。
Eur J Surg Oncol. 2014 Jul;40(7):794-804. doi: 10.1016/j.ejso.2014.03.016. Epub 2014 Apr 3.
6
Management options in locally advanced pancreatic cancer.局部晚期胰腺癌的治疗选择
Curr Oncol Rep. 2014 Jun;16(6):388. doi: 10.1007/s11912-014-0388-y.
7
Cancer statistics, 2014.癌症统计数据,2014 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7.
8
Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks.用于具有竞争风险的删失事件时间的接收者操作特征曲线下时间依赖面积的估计与比较。
Stat Med. 2013 Dec 30;32(30):5381-97. doi: 10.1002/sim.5958. Epub 2013 Sep 12.
9
FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: a meta-analysis.氟代脱氧葡萄糖正电子发射断层扫描在胰腺癌诊断、分期和预后中的作用:荟萃分析。
World J Gastroenterol. 2013 Aug 7;19(29):4808-17. doi: 10.3748/wjg.v19.i29.4808.
10
Borderline resectable pancreatic cancer: pushing the technical limits of surgery.可切除边缘的胰腺癌:挑战手术技术极限
Bull Am Coll Surg. 2013 Jan;98(1):61-3.

利用胰腺癌患者放疗前后的18F-FDG PET图像识别预后性肿瘤内异质性。

Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients.

作者信息

Yue Yong, Osipov Arsen, Fraass Benedick, Sandler Howard, Zhang Xiao, Nissen Nicholas, Hendifar Andrew, Tuli Richard

机构信息

Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

出版信息

J Gastrointest Oncol. 2017 Feb;8(1):127-138. doi: 10.21037/jgo.2016.12.04.

DOI:10.21037/jgo.2016.12.04
PMID:28280617
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5334038/
Abstract

BACKGROUND

To stratify risks of pancreatic adenocarcinoma (PA) patients using pre- and post-radiotherapy (RT) PET/CT images, and to assess the prognostic value of texture variations in predicting therapy response of patients.

METHODS

Twenty-six PA patients treated with RT from 2011-2013 with pre- and post-treatment 18F-FDG-PET/CT scans were identified. Tumor locoregional texture was calculated using 3D kernel-based approach, and texture variations were identified by fitting discrepancies of texture maps of pre- and post-treatment images. A total of 48 texture and clinical variables were identified and evaluated for association with overall survival (OS). The prognostic heterogeneity features were selected using lasso/elastic net regression, and further were evaluated by multivariate Cox analysis.

RESULTS

Median age was 69 y (range, 46-86 y). The texture map and temporal variations between pre- and post-treatment were well characterized by histograms and statistical fitting. The lasso analysis identified seven predictors (age, node stage, post-RT SUVmax, variations of homogeneity, variance, sum mean, and cluster tendency). The multivariate Cox analysis identified five significant variables: age, node stage, variations of homogeneity, variance, and cluster tendency (with P=0.020, 0.040, 0.065, 0.078, and 0.081, respectively). The patients were stratified into two groups based on the risk score of multivariate analysis with log-rank P=0.001: a low risk group (n=11) with a longer mean OS (29.3 months) and higher texture variation (>30%), and a high risk group (n=15) with a shorter mean OS (17.7 months) and lower texture variation (<15%).

CONCLUSIONS

Locoregional metabolic texture response provides a feasible approach for evaluating and predicting clinical outcomes following treatment of PA with RT. The proposed method can be used to stratify patient risk and help select appropriate treatment strategies for individual patients toward implementing response-driven adaptive RT.

摘要

背景

利用放疗前后的PET/CT图像对胰腺腺癌(PA)患者的风险进行分层,并评估纹理变化在预测患者治疗反应中的预后价值。

方法

确定了2011年至2013年接受放疗且治疗前后均进行18F-FDG-PET/CT扫描的26例PA患者。使用基于3D核的方法计算肿瘤局部纹理,并通过拟合治疗前后图像纹理图的差异来识别纹理变化。共识别并评估了48个纹理和临床变量与总生存期(OS)的相关性。使用套索/弹性网络回归选择预后异质性特征,并通过多变量Cox分析进一步评估。

结果

中位年龄为69岁(范围46-86岁)。治疗前后的纹理图和时间变化通过直方图和统计拟合得到了很好的表征。套索分析确定了七个预测因子(年龄、淋巴结分期、放疗后SUVmax、均匀性变化、方差、总和均值以及聚类倾向)。多变量Cox分析确定了五个显著变量:年龄、淋巴结分期、均匀性变化、方差和聚类倾向(P值分别为0.020、0.040、0.065、0.078和0.081)。根据多变量分析的风险评分将患者分为两组,对数秩检验P=0.001:低风险组(n=11),平均OS较长(29.3个月)且纹理变化较高(>30%);高风险组(n=15),平均OS较短(17.7个月)且纹理变化较低(<15%)。

结论

局部代谢纹理反应为评估和预测PA放疗后的临床结果提供了一种可行的方法。所提出的方法可用于对患者风险进行分层,并有助于为个体患者选择合适的治疗策略,以实施反应驱动的自适应放疗。